Corcept Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Conferences Trial results

24 April 2025

ASCO 2025 preview – late-breakers in focus

The curtain lifts on Veritac-2, rusfertide, and another double plenary for Astra.

Trial results

31 March 2025

Surprise win for Corcept's glucocorticoid therapy

Subscribe to Corcept Therapeutics